Resolve Medical launches AI platform to screen supplements, foods and medications

Resolve Medical has launched IntractMD, an AI-powered interaction platform that checks prescriptions alongside supplements, vitamins and foods to surface risks that claims data and electronic health records often miss. The Cleveland company is offering no-cost 60-day pilots to health plans, pharmacy benefit managers, health systems and pharmacy chains.

Why it matters: - Drug interaction risk is a major patient safety issue, especially for older adults and people taking multiple medications. - IntractMD is designed to surface supplement and food conflicts that can be invisible in standard medication records. - The platform aims to give patients, pharmacists and payers one scored view of polypharmacy risk before new products are added to a regimen.

What happened: - Resolve Medical, LLC launched IntractMD, an AI-powered medication interaction platform, on July 29, 2026. - The platform screens prescriptions together with dietary supplements, vitamins and foods. - Resolve Medical is based in Cleveland, Ohio.

The details: - IntractMD screens drug-drug, drug-supplement and drug-food interactions in a single query. - The platform does not require an account, login or installation. - IntractMD returns a Composite Polypharmacy Risk Score, or CPRS, across eight clinical dimensions: bleeding, cardiac, serotonin, narrow-therapeutic-index, CNS, CYP450, renal/hepatic and pharmacodynamic risk. - The platform can also work in reverse, letting a user enter a medication list and see which supplements and foods to avoid. - Resolve Medical says IntractMD uses a pre-computed database of 124,750 drug-pair analyses covering the 500 most-prescribed medications in the United States. - The platform produces output in English and Spanish. - IntractMD is the subject of a U.S. provisional patent application filed in June 2026. - Resolve Medical is offering no-cost, 60-day pilots to health plans, pharmacy benefit managers, health systems and pharmacy chains. - Pilots run on Resolve Medical’s infrastructure and do not require software installation or IT integration from the participating organization. - Resolve Medical says the platform serves patients, health plans, health systems and pharmacies through a patient-facing interaction checker, a proactive supplement screening tool and a pharmacist workflow for medication reviews. - More information is available at Resolve Medical and IntractMD.

Between the lines: - The launch targets a gap in medication safety tools: supplement and food interactions are often absent from claims feeds and electronic health records. - The product appears aimed at workflow adoption because it avoids installation and integration barriers. - The bilingual output suggests the company is trying to make the tool usable across broader patient populations. - The emphasis on proactive screening points to a shift from reacting to interaction problems after a prescription is filled to preventing them before they happen.

What's next: - Resolve Medical is seeking pilot customers across payers, health systems and pharmacy operators. - The company will likely use pilot results to test clinical workflow fit and market demand for broader deployment. - The provisional patent application suggests Resolve Medical may pursue additional intellectual property protection as the platform develops.